Claudia Voena

14PUBLICATIONS
118CO-AUTHORS
Tumour immunologyMolecular targetsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 28, 2026
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Mar 21, 2026
Author Correction: Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Matteo Menotti, Chiara Ambrogio, Taek-Chin Cheong

|Jan 30, 2026
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic Leukemia.

Chiara Pighi, Alessandro Gasparetto, Elisa Genuardi

|Dec 24, 2025
Exportin 1 as a Therapeutic Target to Overcome Drug Resistance in Lung Cancer.

Maria Vittoria Di Marco, Alessandro Gasparetto, Roberto Chiarle

|Mar 07, 2025
ALK in cancer: from function to therapeutic targeting.

Claudia Voena, Chiara Ambrogio, Fabio Iannelli

Pageof 3

Frequent Collaborators

11 joint publications

Roberto Chiarle

7 joint publications

Chiara Ambrogio

4 joint publications

Enrico Patrucco

4 joint publications

Taek-Chin Cheong